12
Participants
Start Date
October 31, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Midazolam, IV
2 milligrams per milliliter (mg/mL) midazolam solution for IV administration. For a 1 mg dose, the midazolam solution (0.5 mL of 2 mg/mL) will be injected at 2 milligrams per minute (mg/min).
Midazolam, oral
0.1 mg/mL midazolam for oral administration. For a 5 mg dose, participants will receive 50 mL of 0.1 mg/mL midazolam.
RO5186582
RO5186582 120 mg film-coated release tablet.
Leeds
Hoffmann-La Roche
INDUSTRY